VP of Corporate Development
Mr. Doug Cooper, MBA is a Managing Director and Head of Research at Beacon Securities Limited, Research Division. Prior to this, Mr. Cooper was the Managing Director of Research and Senior Analyst at Paradigm Capital, Inc., Research Division, covering the special situations sector. Mr. Cooper holds an MBA
Paul Piotrowski is an Equity Research Analyst covering Special Situations at M Partners. Prior to that, Paul served as an Equity Research Associate. Paul covers companies in a variety of industries including cannabis, construction, health care, renewable energy and technology. Before joining M Partners, Paul occupied the position of Analyst at Lexington Park Real Estate Capital Inc. Paul holds an Honours Bachelor of Arts in Economics and Financial Management from Wilfrid Laurier University.
Mr. Douglas Loe is a Managing Director & Analyst for Leede Jones Gable. Mr. Loe is an MBA and holds a Ph.D. in Biochemistry. He brings more than a decade of experience to financial analysis in the global drug development, medical technology, healthcare services and specialty pharmaceutical sectors. Mr. Loe has been recognized as one of Canada’s top healthcare analysts by the Star Mine Analysts Awards, based on the quality of his recommendations to institutional investors. With his extensive knowledge of the healthcare industry, Mr. Loe analyzes and publishes his views on trends in the sector and interprets them within the context of a diversified suite of companies under coverage, many of which locked in substantial returns for investors over the last several quarters.
Chelsea Stellick is an Equity Research Analyst in the Health Care and Biotech space at iA Securities. Chelsea holds a Masters in Health Economics from the University of Alberta and is currently completing her Ph.D. in Medicine (Psychiatry) at the University of Alberta with research focused in the economic modelling of disease progression and in the cost-effectiveness of digital therapeutics. Prior to health care, Chelsea has covered the Midstream & Infrastructure, Energy Services and Energy spaces as an Equity Research Associate.
Justin Keywood is a Healthcare and Special Situations Analyst at Stifel GMP, where he joined in 2012. Mr. Keywood has over 10 years of extensive experience in Financial Analysis spanning across various sectors, with a particular focus on Technology and Healthcare. His unique approach to stock analysis, includes primary-type research in generating specialized insights with customers and industry experts, in order to deeply understand companies and investment opportunities beyond traditional analysis. Prior to joining GMP, Justin worked in business development at a global financial services and software data firm. Justin holds a Bachelor of Business Administration, with a major in Finance from the University of Guelph and is a CFA chaterholder since 2011.
Dick Ryan serves as Vice President, Senior Research Analyst within the Equity Capital Markets division at Colliers Securities. His research coverage includes small-cap companies across several industry sectors including defense and satellite communications, energy-related infrastructure, display and media and general industrial. He joined Colliers in 2008 and has been an analyst for over 20 years. His other work experience includes managing a precious metals mutual fund and working for a public gold company with responsibility for a variety of treasury and investor relations functions. Mr. Ryan earned a Bachelor’s of Arts Degree in Business from the University of St. Thomas. He earned a Master’s of Business Administration Degree from the University of Minnesota.
Tania Gonsalves joined Canaccord Genuity in 2019 as an Analyst covering the Canadian Healthcare Industry. Previously, Ms. Gonsalves worked at an independent dealer for almost four years, most recently as a Research Analyst covering Canadian Healthcare. Prior to her role as an Analyst, Tania spent one year in institutional sales covering US Equities. Tania holds a High Honors Bachelor of Science, with a Specialist in Molecular Biology from the University of Toronto and is a CFA charter holder.
Rahul holds a PhD and MASc in biomedical engineering from the University of Toronto, and an MBA from the University of Oxford. Before joining Raymond James, Rahul was a Healthcare/Biotechnology equities analyst with Paradigm Capital, a boutique investment bank in Toronto. Prior to Paradigm, his roles included Director of Business Development at the Centre for Commercialization of Regenerative Medicine, Investment Manager with the Toronto-based MaRS Investment Accelerator Fund, and Strategic Marketing Analyst with GE Healthcare’s headquarters in the U.K.
Stefan has over 18 years of experience in financial markets identifying promising companies and investment opportunities in the Healthcare sector. Before joining Echelon, Stefan was responsible for Healthcare sector investments as an associate portfolio manager at Sentry/CI Global Asset Management, for funds totaling over $11B in AUM. Previously, he has worked as a Healthcare equity analyst for Morningstar, Macquarie, Orion Securities (acquired by Macquarie) and Desjardins Securities. Stefan started his career as a consultant at the World Bank as part of a satellite and Web-based distance education project called the African Virtual University. Stefan holds an MBA (Finance) and a BSc (Joint Major Biology and Environmental Sciences) from McGill University and is CFA charterholder.
Biography coming soon.